On March 14, New York State Police arrived at a Steuben County home and learned a man’s in-home caregiver, later identified ...
4hon MSN
More than 800 people have been treated with Elevidys, the only approved treatment for Duchenne muscular dystrophy, the company said.
5h
Zacks Small Cap Research on MSNDWTX: First Patient Dosed in Phase 2b Trial of Halneuron in CINP; Debt Conversion Strengthens Balance Sheet…DWTX READ THE FULL DWTX RESEARCH REPORT Business Update First Patient Dosed in Phase 2b Trial of Halneuron® On March 18, 2025 ...
Sarepta Therapeutics shares dropped 20% after a patient's death raises Elevidys safety concerns. Read why I am downgrading ...
For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic ...
Direct-to-patient companies are bringing much-needed disruption to the current healthcare system, challenging payers, ...
Dominic, 26, fell ill during the second wave of the pandemic in late 2020, and was in intensive care for three months.
Dental patient Michael Beesler, 61, died 3 days after Dr. Scott Schumann's office called 911 reporting he was sedated and not breathing.
A patient drive for those who may qualify for medical cannabis or those simply seeking information will take place on ...
Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and patient data in drug discovery and development. The collaboration will ...
Shares of Sarepta Therapeutics fell after the company said a patient with Duchenne muscular dystrophy died of liver failure after using its Elevidys treatment. The stock opened the market down 22% at ...
Police say the unlicensed dentist injured multiple people, targeting the Hispanic community and those who were undocumented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results